Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berrettini

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Blood|May 1, 1988
High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterizationF van Iwaarden, P G de Groot, J J Sixma, et al.
Thrombosis Research|October 1, 1988
Immunoblotting studies of the molecular forms of protein C in plasmaM J Heeb, H P Schwarz, T White, et al.
The Journal of Clinical Investigation|March 21, 1998
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generationP Gresele, S Momi, M Berrettini, et al.
Blood|August 1, 1986
Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodiesM Berrettini, B Lämmle, T White, et al.
Thrombosis and Haemostasis|April 8, 1988
Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XIB Lämmle, B L Zuraw, M J Heeb, et al.
Thrombosis and Haemostasis|December 15, 1986
Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and PerugiaP Reber, M Furlan, A Henschen, et al.
Stroke|May 1, 1987
Fatty acid pattern of red blood cell membranes and risk of ischemic brain infarction: a case-control studyS Ricci, L Patoia, M Berrettini, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)G Finazzi, R Marchioli, V Brancaccio, et al.
British Journal of Haematology|August 1, 1985
Carrier detection in factor VII congenital deficiencyG Mariani, J Hermans, M Orlando, et al.
Lancet (London, England)|August 17, 1996
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant TherapyG Palareti, N Leali, S Coccheri, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Blood|May 1, 1988
High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterizationF van Iwaarden, P G de Groot, J J Sixma, et al.
Thrombosis Research|October 1, 1988
Immunoblotting studies of the molecular forms of protein C in plasmaM J Heeb, H P Schwarz, T White, et al.
The Journal of Clinical Investigation|March 21, 1998
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generationP Gresele, S Momi, M Berrettini, et al.
Blood|August 1, 1986
Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodiesM Berrettini, B Lämmle, T White, et al.
Thrombosis and Haemostasis|April 8, 1988
Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XIB Lämmle, B L Zuraw, M J Heeb, et al.
Thrombosis and Haemostasis|December 15, 1986
Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and PerugiaP Reber, M Furlan, A Henschen, et al.
Stroke|May 1, 1987
Fatty acid pattern of red blood cell membranes and risk of ischemic brain infarction: a case-control studyS Ricci, L Patoia, M Berrettini, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)G Finazzi, R Marchioli, V Brancaccio, et al.
British Journal of Haematology|August 1, 1985
Carrier detection in factor VII congenital deficiencyG Mariani, J Hermans, M Orlando, et al.
Lancet (London, England)|August 17, 1996
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant TherapyG Palareti, N Leali, S Coccheri, et al.
Pageof 6